Organogenesis Holdings (ORGO) Gross Profit (2017 - 2025)
Historic Gross Profit for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $97.7 million.
- Organogenesis Holdings' Gross Profit rose 1049.43% to $97.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $308.3 million, marking a year-over-year decrease of 1000.76%. This contributed to the annual value of $366.3 million for FY2024, which is 1213.59% up from last year.
- Organogenesis Holdings' Gross Profit amounted to $97.7 million in Q3 2025, which was up 1049.43% from $52.1 million recorded in Q2 2025.
- In the past 5 years, Organogenesis Holdings' Gross Profit registered a high of $101.0 million during Q2 2024, and its lowest value of $52.1 million during Q2 2025.
- Over the past 5 years, Organogenesis Holdings' median Gross Profit value was $88.4 million (recorded in 2024), while the average stood at $84.5 million.
- As far as peak fluctuations go, Organogenesis Holdings' Gross Profit soared by 9063.74% in 2021, and later tumbled by 4846.99% in 2025.
- Over the past 5 years, Organogenesis Holdings' Gross Profit (Quarter) stood at $95.3 million in 2021, then fell by 7.2% to $88.4 million in 2022, then dropped by 18.69% to $71.9 million in 2023, then skyrocketed by 33.0% to $95.6 million in 2024, then grew by 2.15% to $97.7 million in 2025.
- Its last three reported values are $97.7 million in Q3 2025, $52.1 million for Q2 2025, and $63.0 million during Q1 2025.